Investment Summary |
|
|---|---|
| Date | 2019-04-01 |
| Target | SpringWorks Therapeutics |
| Sector | Life Science |
| Investor(s) |
HBM Partners
BVF Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 27 of 65 |
| Sector: Life Science M&A | 21 of 56 |
| Type: Venture M&A Deals | 19 of 52 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 16 of 44 |
| Year: 2019 M&A | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-26 |
Adrenomed
Berlin, Germany Adrenomed is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. Adrenomed was founded in 2009 and is based in Berlin, Germany. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-18 |
Hookipa
New York, New York, United States Hookipa is a clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology. Hookipa was founded in 2011 and is based in New York, New York. |
Sell | - |
BVF Partners LP is a private investment firm focused on providing long-term investments in small-cap public biotechnology companies. Prospective transaction types include management buyouts, recapitalizations, and venture. BVF Partners was formed in 1993 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science M&A | 1 of 3 |
| Type: Venture M&A Deals | 1 of 2 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 1 of 3 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-13 |
SpringWorks Therapeutics
Stamford, Connecticut, United States SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. SpringWorks Therapeutics was founded in 2017 and is based in Stamford, Connecticut. |
Sell | - |
